Marked rise in BP.
Adrenaline should not be given to patients receiving β blockers.
Source: KDT 7e · p133
Beta Blocker · Antiglaucoma agent
Betaxolol is a β1-selective adrenergic receptor antagonist that competitively blocks β1-adrenoceptors, primarily in the heart. This action inhibits the Gs protein-mediated increase in intracellular cyclic AMP (cAMP) typically induced by catecholamines. The clinical consequence is a reduction in heart rate and myocardial contractility, leading to a decrease in cardiac output and blood pressure.
Beta-blockers may cause intra-uterine
Marked rise in BP.
Adrenaline should not be given to patients receiving β blockers.
Source: KDT 7e · p133
Hyperkalaemia more likely.
Source: KDT 7e
Severe bradycardia.
Extreme caution advised if amiodarone is co-administered with sofosbuvir and a beta blocker.
Source: Harrison 22e · unknown
Drug interaction classified as: antagonism
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Increased propensity for AV block, severe bradycardia, and decreased left ventricular function.
Avoid concurrent administration. The concurrent administration of diltiazem with a beta blocker is contraindicated.
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: antagonism
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: KD Tripathi 7e, Goodman & Gilman 14e, BNF·Verified: 2026-05-13 · House clinical team